FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Wednesday reported third-quarter net income of $1.25 billion.
On a per-share basis, the Foster City, California-based company said it had net income of $1. Earnings, adjusted for non-recurring costs, were $2.02 per share.
The results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.58 per share.
The HIV and hepatitis C drugmaker posted revenue of $7.55 billion in the period, which also topped Street forecasts. Nine analysts surveyed by Zacks expected $6.99 billion.
Gilead expects full-year earnings in the range of $4.25 to $4.45 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD
